Literature DB >> 27376703

The use of cone beam CT in achieving unipedicular spinal augmentation.

Terrence C H Hui1, Gideon Z L Tan2, Alvin K W Tan2, Uei Pua1.   

Abstract

OBJECTIVE: To assess the feasibility of cone beam CT (CBCT) in achieving unipedicular access during spinal cement augmentation.
METHODS: A retrospective review of all patients who underwent CBCT-guided unipedicular spinal augmentation procedures between 1 January 2012 and 15 June 2015 was performed. 59 patients (43 females 16 males; mean-age, 74.0 years; range, 52-90 years) underwent unipedicular spinal augmentation in 78 vertebral levels (T5-T9, n = 14; T10-L2, n = 42; L3-L5, n = 22). Degree of cross-over in contralateral hemivertebral body, complications and 30-day mortality were recorded.
RESULTS: 97% (76/78) of procedures were technically successful. Two procedures failed owing to vertebral sclerosis. For vertebroplasty, all cases (6/6) demonstrated cross-over filling of cement and 50% (3/6) showed cement cross-over >50% of contralateral half of the vertebral body. For kyphoplasty, 13 out of 15 procedures demonstrated balloon and cement cross-over >50% of contralateral half of the vertebral body. Two kyphoplasty procedures required the second pedicle after midline cross-over of cement failed. Of the kyphoplasty procedures that were successfully performed with the unipedicular approach, 76.9% (10/13) showed cement cross-over >50% of contralateral half of the vertebral body. For stentoplasty, all cases (55/55) showed midline stent-cement complex cross-over and 78.2% (43/55) exhibited stent-cement complex cross-over >50% of contralateral half of the vertebral body. There was no major complication or mortality. Minor complications included asymptomatic cement extravasation (6.4%, n = 5) and self-limiting haematoma (1.3%, n = 1).
CONCLUSION: Unipedicular access for spinal augmentation procedures is achieved at a high success rate with the use of CBCT. ADVANCES IN KNOWLEDGE: This article describes the novel use of CBCT to achieve unipedicular spinal augmentation. Unipedicular spinal augmentation has the potential to reduce risk, duration, radiation and cost while achieving similar results.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27376703      PMCID: PMC5124915          DOI: 10.1259/bjr.20160030

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

1.  Unilateral transpedicular percutaneous vertebroplasty: initial experience.

Authors:  Ann K Kim; Mary E Jensen; Jacques E Dion; Patricia A Schweickert; Timothy J Kaufmann; David F Kallmes
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

2.  Percutaneous vertebroplasty: preliminary experiences with rotational acquisitions and 3D reconstructions for therapy control.

Authors:  Roman Hodek-Wuerz; Jean-Baptiste Martin; Kai Wilhelm; Karl O Lovblad; Drazenko Babic; Daniel A Rufenacht; Stefan G Wetzel
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Sep-Oct       Impact factor: 2.740

3.  Feasibility study of needle placement in percutaneous vertebroplasty: cone-beam computed tomography guidance versus conventional fluoroscopy.

Authors:  Sicco J Braak; Kirsten Zuurmond; Hans C J Aerts; Marc van Leersum; Timotheus T Th Overtoom; Johannes P M van Heesewijk; Marco J L van Strijen
Journal:  Cardiovasc Intervent Radiol       Date:  2013-03-20       Impact factor: 2.740

4.  Comparison of unipedicular and bipedicular balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures: a prospective randomised study.

Authors:  B J Rebolledo; B P Gladnick; A Unnanuntana; J T Nguyen; C K Kepler; J M Lane
Journal:  Bone Joint J       Date:  2013-03       Impact factor: 5.082

5.  Biomechanical effects of unipedicular vertebroplasty on intact vertebrae.

Authors:  Kathryn B Higgins; Robert D Harten; Noshir A Langrana; Mitchell F Reiter
Journal:  Spine (Phila Pa 1976)       Date:  2003-07-15       Impact factor: 3.468

6.  Unipedicular balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures: early results.

Authors:  Elias C Papadopoulos; Folorunsho Edobor-Osula; Michael J Gardner; Michael K Shindle; Joseph M Lane
Journal:  J Spinal Disord Tech       Date:  2008-12

Review 7.  Is unilateral kyphoplasty as effective and safe as bilateral kyphoplasties for osteoporotic vertebral compression fractures? A meta-analysis.

Authors:  Zhaobo Huang; Shuanglin Wan; Lei Ning; Shiliang Han
Journal:  Clin Orthop Relat Res       Date:  2014-06-26       Impact factor: 4.176

8.  A randomized trial of vertebroplasty for osteoporotic spinal fractures.

Authors:  David F Kallmes; Bryan A Comstock; Patrick J Heagerty; Judith A Turner; David J Wilson; Terry H Diamond; Richard Edwards; Leigh A Gray; Lydia Stout; Sara Owen; William Hollingworth; Basavaraj Ghdoke; Deborah J Annesley-Williams; Stuart H Ralston; Jeffrey G Jarvik
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

9.  Osseofix® system for percutaneous stabilization of osteoporotic and tumorous vertebral compression fractures - clinical and radiological results after 12 months.

Authors:  S A Ender; G Gradl; M Ender; S Langner; H R Merk; R Kayser
Journal:  Rofo       Date:  2013-10-18

10.  A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters.

Authors:  Jan Van Meirhaeghe; Leonard Bastian; Steven Boonen; Jonas Ranstam; John B Tillman; Douglas Wardlaw
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-20       Impact factor: 3.468

View more
  2 in total

Review 1.  [Vertebroplasty and kyphoplasty : A critical statement].

Authors:  Sönke Langner; Christian Henker
Journal:  Radiologe       Date:  2020-02       Impact factor: 0.635

2.  Kambin triangle approach in percutaneous vertebroplasty for the treatment of osteoporotic vertebral compression fractures.

Authors:  Ye-Feng Wang; Jun Shen; Suo-Yuan Li; Xiao Yu; Tian-Ming Zou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.